GessainA and CassarO: Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol, 2012; 3:388.
2.
VerdonckK, GonzalezE, Van DoorenS, VandammeAM, VanhamG, and GotuzzoE: Human T-lymphotropic virus 1: Recent knowledge about an ancient infection. Lancet Infect Dis, 2007; 7(4):266–281.
3.
MoriuchiH, MasuzakiH, DoiH, and KatamineS: Mother-to-child transmission of human T-cell lymphotropic virus type 1. Pediat Infect J, 2013; 32(2):175–177.
4.
AhmedS, KimMH, SugandhiN, et al.: Beyond early infant diagnosis: Case finding strategies for identification of HIV-infected infants and children. AIDS, 2013; 27(Suppl 2):S235–245.
5.
HillSA, LloydPA, McDonaldS, WykoffJ, and DerseD: Susceptibility of human T cell leukemia virus type I to nucleoside reverse transcriptase inhibitors. J Infect Dis, 2003; 188(3):424–427.
6.
MacchiB, FaraoniI, ZhangJ, et al.: AZT inhibits the transmission of human T cell leukaemia/lymphoma virus type I to adult peripheral blood mononuclear cells in vitro. J Gen Virol, 1997; 78(Pt 5):1007–1016.
